Substrate LabsHot
Series A·1dPD
DealFilter covers the full inbound-to-portfolio lifecycle. Each surface is built for one specific moment in a partner’s day — the morning read, the inbox triage, the deal you’re chasing, the company you backed.
Three inbound deals cleared threshold overnight. The one worth opening first is Substrate Labs — Series A, robotics warehouse OS, thesis-fit 9.2. Lumino needs a reply by Friday; the partner-meeting summary you wrote Tuesday already flagged the open question on retention. Helix is interesting but the founder claim on regulatory timing reads thin — worth a 15-minute call before the memo.
You’ve seen six fintech infra pitches this week, up from a 2-per-week baseline. Three name the same incumbent. Worth a thesis check?
To help me score future pitches more like you would: on the Helix deal, how heavily should the founder’s prior regulatory experience factor in?
| # | Company | Stage | Score | Th · St · Mk · Tm · Tr | Confidence | Status |
|---|---|---|---|---|---|---|
| 01 | Substrate Labs | Series A | 8.4 | Th St Mk Tm Tr | High | Memo ready |
| 02 | Northbeam Capital | Seed | 7.1 | Th St Mk Tm Tr | Medium | Above threshold |
| 03 | Halcyon Robotics | Series B | 6.8 | Th St Mk Tm Tr | Medium | Watchlist |
| 04 | Quartile Health | Pre-seed | 5.9 | Th St Mk Tm Tr | Low | Below threshold |
| 05 | Linework AI | Seed | 5.2 | Th St Mk Tm Tr | Medium | Below threshold |
| Company | Sector | Entry | Invested | Implied val. | Status |
|---|---|---|---|---|---|
| Atlas Robotics | Robotics | Series A · 2022 | $14.0M | $186M | Active |
| Cargosync | Logistics | Series A · 2022 | $10.0M | $99M | Active |
| Lumino | SMB Software | Seed · 2023 | $8.5M | $53.5M | Active |
| Riverbend Health | Women's Health | Series A · 2024 | $9.0M | $62.5M | Active |
| Finpath | Fintech | Seed · 2020 | $3.5M | Acquired by Citizens | Exited |
| Conduit | Logistics | Series A · 2019 | $3.0M | Secondary · GA | Exited |
For emerging managers
For established funds